Summary Statistics for Models to Predict Women with at Least One major osteoporotic fracture and who never received any antiosteoporotic.

Nazzarena Malavolta
Claudio Ripamonti
Istituto Ortopedico Rizzoli

September 2016

SAVERIO GNUDI,1 NAZZARENA MALAVOLTA,2 LUCIA LISI,2 and CLAUDIO RIPAMONTI1 Low bone mineral density (...

Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW)

Diez-Perez, Adolfo
Adachi, Jonathan D.
Adami, Silvano
Anderson, Frederick A., Jr.
Boonen, Steven
, Roland D.
Compston, Juliet E.
Cooper, Cyrus
Gehlbach, Stephen H.
Greenspan, Susan L.
Hooven, Fred H.
LaCroix, Andrea Z.
Nieves, Jeri W.
Netelenbos, J. Coen
Pfeilschifter, Johannes
Rossini, Maurizio
Roux, Christian
Saag, Kenneth G.
Silverman, Stuart
Siris, Ethel S.
Wyman, Allison
Rushton-Smith, Sophie
Watts, Nelson B.
Global Longitudinal Study of Osteoporosis in Women (GLOW) Investigators

January 2014

Antiosteoporosis medication (AOM) does not abolish fracture risk, and some individuals experience mu...

FRAXH: Prediction of Major Osteoporotic Fractures in Women from the General Population: The OPUS Study

Karine Briot
Simon Paternotte
Sami Kolta
Richard Eastell
Dieter Felsenberg
David M. Reid

August 2016

Purposes: The aim of this study was to analyse how well FRAXH predicts the risk of major osteoporoti...

Summary Statistics for Models to Predict Women with at Least One major osteoporotic fracture and who received any antiosteoporotic treatment.

Karine Briot (503455)
Simon Paternotte (503456)
Sami Kolta (503457)
Richard Eastell (153287)
Dieter Felsenberg (223848)
David M. Reid (223874)
Claus-C. Glüer (223850)
Christian Roux (223877)

December 2013

Summary Statistics for Models to Predict Women with at Least One major osteoporotic fracture and ...

Summary statistics for models to predict women with incident major osteoporotic fracture in the whole population.

Karine Briot (503455)
Simon Paternotte (503456)
Sami Kolta (503457)
Richard Eastell (153287)
Dieter Felsenberg (223848)
David M. Reid (223874)
Claus-C. Glüer (223850)
Christian Roux (223877)

December 2013

Summary statistics for models to predict women with incident major osteoporotic fracture in the w...

Summary statistics for models to predict women with at least one radiographically detected Vertebral Fracture.

Karine Briot (503455)
Simon Paternotte (503456)
Sami Kolta (503457)
Richard Eastell (153287)
Dieter Felsenberg (223848)
David M. Reid (223874)
Claus-C. Glüer (223850)
Christian Roux (223877)

December 2013

Summary statistics for models to predict women with at least one radiographically detected Verteb...

ROC curves for models to predict women with incident major osteoporotic fractures in the whole population.

Karine Briot (503455)
Simon Paternotte (503456)
Sami Kolta (503457)
Richard Eastell (153287)
Dieter Felsenberg (223848)
David M. Reid (223874)
Claus-C. Glüer (223850)
Christian Roux (223877)

December 2013

ROC curves for models to predict women with incident major osteoporotic fractures in the whole po...

FRAX®: Prediction of Major Osteoporotic Fractures in Women from the General Population: The OPUS Study

Briot Karine
Paternotte Simon
Kolta Sami
Eastell Richard
Felsenberg Dieter
Reid David M.
Glüer Claus-C.
Roux Christian

December 2013

The aim of this study was to analyse how well FRAX® predicts the risk of major osteoporotic and vert...

Age- and sex-specific observed incidence rates of major osteoporotic fracture as compared to those predicted by the imputation method.

Corinne Klop (833463)
Paco M. J. Welsing (833464)
Hubert G. M. Leufkens (193774)
Petra J. M. Elders (683542)
Jetty A. Overbeek (833465)
Joop P. van den Bergh (833466)
Johannes W. J. Bijlsma (833467)
Frank de Vries (430757)

December 2015

Age- and sex-specific observed incidence rates of major osteoporotic fracture as compared to thos...

Concordance between the predicted and observed risk of non-vertebral osteoporotic fracture (upper panel) and hip fracture (lower panel) in the Tromsø Study cohort, according to the Garvan nomograms.

Luai A. Ahmed (634456)
Nguyen D. Nguyen (634457)
Åshild Bjørnerem (634458)
Ragnar M. Joakimsen (634459)
Lone Jørgensen (634460)
Jan Størmer (634461)
Dana Bliuc (634462)
Jacqueline R. Center (223845)
John A. Eisman (153234)
Tuan V. Nguyen (223867)
Nina Emaus (634463)

September 2014

(A): Quintile cut-offs for the predicted 10-year risk (%) of non-vertebral osteoporotic fracture ...

Baseline characteristics of women who ever received antiosteoporotic treatment t with (n = 50) and without incident major osteoporotic fractures (n = 1000) during the follow-up (n = 1050).

Karine Briot (503455)
Simon Paternotte (503456)
Sami Kolta (503457)
Richard Eastell (153287)
Dieter Felsenberg (223848)
David M. Reid (223874)
Claus-C. Glüer (223850)
Christian Roux (223877)

December 2013

Baseline characteristics of women who ever received antiosteoporotic treatment t with (n = 50) an...

Risk factors for treatment failure with antiosteoporosis medication: The global longitudinal study of osteoporosis in women (GLOW).

Díez Pérez A
Adachi JD
ADAMI, Silvano
Anderson FA Jr
Boonen S
Chapurlat R
Compston JE
Cooper C
Gehlbach SH
Greenspan SL
Hooven FH
Lacroix AZ
Nieves JW
Netelenbos JC
Pfeilschifter J
ROSSINI, Maurizio
Roux C
Saag KG
Silverman S
Siris ES
Wyman A
Rushton Smith SK
Watts NB

January 2014

Anti-osteoporosis medication (AOM) does not abolish fracture risk, and some individuals experience m...

Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW).

Díez-Pérez, A
Adachi, JD
Adami, S
Anderson, FA
Boonen, S
Chapurlat, R
Compston, JE
Cooper, C
Gehlbach, SH
Greenspan, SL
Hooven, FH
LaCroix, AZ
Nieves, JW
Netelenbos, JC
Pfeilschifter, J
Rossini, M
Roux, C
Saag, KG
Silverman, S
Siris, ES
Wyman, A
Rushton-Smith, SK
Watts, NB

January 2014

Antiosteoporosis medication (AOM) does not abolish fracture risk, and some individuals experience mu...

WHO absolute fracture risk models (FRAX): Do clinical risk factors improve fracture prediction in older women without osteoporosis?

Hillier, TA
Cauley, JA
Rizzo, JH
Pedula, KL
Ensrud, KE
Bauer, DC
Lui, LY
Vesco, KK
Black, DM
Donaldson, MG
Leblanc, ES
Cummings, SR

August 2011

Bone mineral density (BMD) is a strong predictor of fracture, yet most fractures occur in women with...

Predicting fractures in an international cohort using risk factor algorithms without BMD

Sambrook, Philip N
Flahive, Julie
Hooven, Fred H
Boonen, Steven
Chapurlat, Roland
Lindsay, Robert
Nguyen, Tuan V
Díez‐Perez, Adolfo
Pfeilschifter, Johannes
Greenspan, Susan L
Hosmer, David
Netelenbos, J Coen
Adachi, Jonathan D
Watts, Nelson B
Cooper, Cyrus
Roux, Christian
Rossini, Maurizio
Siris, Ethel S
Silverman, Stuart
Saag, Kenneth G
Compston, Juliet E
LaCroix, Andrea
Gehlbach, Stephen

November 2011

Clinical risk factors are associated with increased probability of fracture in postmenopausal women....

SEE PROFILE

Nazzarena Malavolta
Claudio Ripamonti
Istituto Ortopedico Rizzoli

September 2016

SAVERIO GNUDI,1 NAZZARENA MALAVOLTA,2 LUCIA LISI,2 and CLAUDIO RIPAMONTI1 Low bone mineral density (...

Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW)

Diez-Perez, Adolfo
Adachi, Jonathan D.
Adami, Silvano
Anderson, Frederick A., Jr.
Boonen, Steven
, Roland D.
Compston, Juliet E.
Cooper, Cyrus
Gehlbach, Stephen H.
Greenspan, Susan L.
Hooven, Fred H.
LaCroix, Andrea Z.
Nieves, Jeri W.
Netelenbos, J. Coen
Pfeilschifter, Johannes
Rossini, Maurizio
Roux, Christian
Saag, Kenneth G.
Silverman, Stuart
Siris, Ethel S.
Wyman, Allison
Rushton-Smith, Sophie
Watts, Nelson B.
Global Longitudinal Study of Osteoporosis in Women (GLOW) Investigators

January 2014

Antiosteoporosis medication (AOM) does not abolish fracture risk, and some individuals experience mu...

FRAXH: Prediction of Major Osteoporotic Fractures in Women from the General Population: The OPUS Study

Karine Briot
Simon Paternotte
Sami Kolta
Richard Eastell
Dieter Felsenberg
David M. Reid

August 2016

Purposes: The aim of this study was to analyse how well FRAXH predicts the risk of major osteoporoti...

Summary Statistics for Models to Predict Women with at Least One major osteoporotic fracture and who received any antiosteoporotic treatment.

Karine Briot (503455)
Simon Paternotte (503456)
Sami Kolta (503457)
Richard Eastell (153287)
Dieter Felsenberg (223848)
David M. Reid (223874)
Claus-C. Glüer (223850)
Christian Roux (223877)

December 2013

Summary Statistics for Models to Predict Women with at Least One major osteoporotic fracture and ...

Summary statistics for models to predict women with incident major osteoporotic fracture in the whole population.

Karine Briot (503455)
Simon Paternotte (503456)
Sami Kolta (503457)
Richard Eastell (153287)
Dieter Felsenberg (223848)
David M. Reid (223874)
Claus-C. Glüer (223850)
Christian Roux (223877)

December 2013

Summary statistics for models to predict women with incident major osteoporotic fracture in the w...

Summary statistics for models to predict women with at least one radiographically detected Vertebral Fracture.

Karine Briot (503455)
Simon Paternotte (503456)
Sami Kolta (503457)
Richard Eastell (153287)
Dieter Felsenberg (223848)
David M. Reid (223874)
Claus-C. Glüer (223850)
Christian Roux (223877)

December 2013

Summary statistics for models to predict women with at least one radiographically detected Verteb...

ROC curves for models to predict women with incident major osteoporotic fractures in the whole population.

Karine Briot (503455)
Simon Paternotte (503456)
Sami Kolta (503457)
Richard Eastell (153287)
Dieter Felsenberg (223848)
David M. Reid (223874)
Claus-C. Glüer (223850)
Christian Roux (223877)

December 2013

ROC curves for models to predict women with incident major osteoporotic fractures in the whole po...

FRAX®: Prediction of Major Osteoporotic Fractures in Women from the General Population: The OPUS Study

Briot Karine
Paternotte Simon
Kolta Sami
Eastell Richard
Felsenberg Dieter
Reid David M.
Glüer Claus-C.
Roux Christian

December 2013

The aim of this study was to analyse how well FRAX® predicts the risk of major osteoporotic and vert...

Age- and sex-specific observed incidence rates of major osteoporotic fracture as compared to those predicted by the imputation method.

Corinne Klop (833463)
Paco M. J. Welsing (833464)
Hubert G. M. Leufkens (193774)
Petra J. M. Elders (683542)
Jetty A. Overbeek (833465)
Joop P. van den Bergh (833466)
Johannes W. J. Bijlsma (833467)
Frank de Vries (430757)

December 2015

Age- and sex-specific observed incidence rates of major osteoporotic fracture as compared to thos...

Concordance between the predicted and observed risk of non-vertebral osteoporotic fracture (upper panel) and hip fracture (lower panel) in the Tromsø Study cohort, according to the Garvan nomograms.

Luai A. Ahmed (634456)
Nguyen D. Nguyen (634457)
Åshild Bjørnerem (634458)
Ragnar M. Joakimsen (634459)
Lone Jørgensen (634460)
Jan Størmer (634461)
Dana Bliuc (634462)
Jacqueline R. Center (223845)
John A. Eisman (153234)
Tuan V. Nguyen (223867)
Nina Emaus (634463)

September 2014

(A): Quintile cut-offs for the predicted 10-year risk (%) of non-vertebral osteoporotic fracture ...

Baseline characteristics of women who ever received antiosteoporotic treatment t with (n = 50) and without incident major osteoporotic fractures (n = 1000) during the follow-up (n = 1050).

Karine Briot (503455)
Simon Paternotte (503456)
Sami Kolta (503457)
Richard Eastell (153287)
Dieter Felsenberg (223848)
David M. Reid (223874)
Claus-C. Glüer (223850)
Christian Roux (223877)

December 2013

Baseline characteristics of women who ever received antiosteoporotic treatment t with (n = 50) an...

Risk factors for treatment failure with antiosteoporosis medication: The global longitudinal study of osteoporosis in women (GLOW).

Díez Pérez A
Adachi JD
ADAMI, Silvano
Anderson FA Jr
Boonen S
Chapurlat R
Compston JE
Cooper C
Gehlbach SH
Greenspan SL
Hooven FH
Lacroix AZ
Nieves JW
Netelenbos JC
Pfeilschifter J
ROSSINI, Maurizio
Roux C
Saag KG
Silverman S
Siris ES
Wyman A
Rushton Smith SK
Watts NB

January 2014

Anti-osteoporosis medication (AOM) does not abolish fracture risk, and some individuals experience m...

Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW).

Díez-Pérez, A
Adachi, JD
Adami, S
Anderson, FA
Boonen, S
Chapurlat, R
Compston, JE
Cooper, C
Gehlbach, SH
Greenspan, SL
Hooven, FH
LaCroix, AZ
Nieves, JW
Netelenbos, JC
Pfeilschifter, J
Rossini, M
Roux, C
Saag, KG
Silverman, S
Siris, ES
Wyman, A
Rushton-Smith, SK
Watts, NB

January 2014

Antiosteoporosis medication (AOM) does not abolish fracture risk, and some individuals experience mu...

WHO absolute fracture risk models (FRAX): Do clinical risk factors improve fracture prediction in older women without osteoporosis?

Hillier, TA
Cauley, JA
Rizzo, JH
Pedula, KL
Ensrud, KE
Bauer, DC
Lui, LY
Vesco, KK
Black, DM
Donaldson, MG
Leblanc, ES
Cummings, SR

August 2011

Bone mineral density (BMD) is a strong predictor of fracture, yet most fractures occur in women with...

Predicting fractures in an international cohort using risk factor algorithms without BMD

Sambrook, Philip N
Flahive, Julie
Hooven, Fred H
Boonen, Steven
Chapurlat, Roland
Lindsay, Robert
Nguyen, Tuan V
Díez‐Perez, Adolfo
Pfeilschifter, Johannes
Greenspan, Susan L
Hosmer, David
Netelenbos, J Coen
Adachi, Jonathan D
Watts, Nelson B
Cooper, Cyrus
Roux, Christian
Rossini, Maurizio
Siris, Ethel S
Silverman, Stuart
Saag, Kenneth G
Compston, Juliet E
LaCroix, Andrea
Gehlbach, Stephen

November 2011

Clinical risk factors are associated with increased probability of fracture in postmenopausal women....

SEE PROFILE

Nazzarena Malavolta
Claudio Ripamonti
Istituto Ortopedico Rizzoli

September 2016

SAVERIO GNUDI,1 NAZZARENA MALAVOLTA,2 LUCIA LISI,2 and CLAUDIO RIPAMONTI1 Low bone mineral density (...

Risk Factors for Treatment Failure With Antiosteoporosis Medication: The Global Longitudinal Study of Osteoporosis in Women (GLOW)

Diez-Perez, Adolfo
Adachi, Jonathan D.
Adami, Silvano
Anderson, Frederick A., Jr.
Boonen, Steven
, Roland D.
Compston, Juliet E.
Cooper, Cyrus
Gehlbach, Stephen H.
Greenspan, Susan L.
Hooven, Fred H.
LaCroix, Andrea Z.
Nieves, Jeri W.
Netelenbos, J. Coen
Pfeilschifter, Johannes
Rossini, Maurizio
Roux, Christian
Saag, Kenneth G.
Silverman, Stuart
Siris, Ethel S.
Wyman, Allison
Rushton-Smith, Sophie
Watts, Nelson B.
Global Longitudinal Study of Osteoporosis in Women (GLOW) Investigators

January 2014

Antiosteoporosis medication (AOM) does not abolish fracture risk, and some individuals experience mu...

FRAXH: Prediction of Major Osteoporotic Fractures in Women from the General Population: The OPUS Study

Karine Briot
Simon Paternotte
Sami Kolta
Richard Eastell
Dieter Felsenberg
David M. Reid

August 2016

Purposes: The aim of this study was to analyse how well FRAXH predicts the risk of major osteoporoti...

Summary Statistics for Models to Predict Women with at Least One major osteoporotic fracture and who never received any antiosteoporotic.

Abstract

Extracted data

Summary Statistics for Models to Predict Women with at Least One major osteoporotic fracture and who never received any antiosteoporotic.

Abstract

Extracted data

Related items

Related items